The reduced growth by PPARγ ligands such as GW1929, PGJ2, ciglitazone, Tro, and rosiglitazone was related to a substantial reduction in EP2 mRNA and protein levels in human NSCLC cell lines (H1838 and H2106). This evidence concerns the gene PPARG and non-small cell lung carcinoma.